Latest Commercialisation Strategy News

Page 6 of 8
Proteomics International has launched PromarkerD, a pioneering blood test that predicts diabetic kidney disease years before symptoms, marking its entry into the vast US healthcare market.
Ada Torres
Ada Torres
20 June 2025
Hazer Group Limited has opened a $2 million underwritten Share Purchase Plan, offering eligible shareholders in Australia and New Zealand the chance to buy shares at the same price as a recent institutional placement. The funds will support the commercialisation of its methane reactor technology and synthetic graphite development.
Maxwell Dee
Maxwell Dee
18 June 2025
Clarity Pharmaceuticals has partnered with SpectronRx to manufacture and distribute its lead prostate cancer diagnostic, Cu-64 SAR-bisPSMA, at commercial scale across the US. This agreement sets the stage for a seamless launch pending FDA approval.
Ada Torres
Ada Torres
17 June 2025
HeraMED has partnered with RMIT University and the Digital Health CRC to develop AI-driven maternity care models focused on culturally diverse populations, aiming to improve pre-term delivery risk prediction and personalised care.
Ada Torres
Ada Torres
16 June 2025
Hazer Group has raised A$8 million through a share placement and launched a A$2 million Share Purchase Plan to accelerate its clean hydrogen and graphite technology commercialisation.
Maxwell Dee
Maxwell Dee
16 June 2025
FBR Limited has secured a pivotal engineering agreement with Samsung Heavy Industries to develop a shipbuilding automation robot, marking a significant step in industrial robotics innovation.
Victor Sage
Victor Sage
16 June 2025
Omega Oil and Gas has extinguished a 3% royalty on its Queensland liquids production by paying TAG Oil US$1 million, clearing the way for greater commercial flexibility following promising flow tests at Canyon-1H.
Maxwell Dee
Maxwell Dee
10 June 2025
Tivan Limited has received $150,000 in exploration grants from the Northern Territory Government to advance its promising Sandover Fluorite Project, supporting maiden drilling and metallurgical testwork.
Maxwell Dee
Maxwell Dee
6 June 2025
Avecho Biotechnology has received $1.66 million from the Australian Government’s R&D Tax Incentive, reinforcing its commitment to a pivotal Phase III trial for its CBD-based insomnia treatment and accelerating its commercial ambitions.
Ada Torres
Ada Torres
28 May 2025
EBR Systems has announced a fully underwritten A$55.9 million capital raise alongside a Security Purchase Plan to fund the commercial rollout of its FDA-approved WiSE CRT System, targeting a US$3.6 billion market opportunity in cardiac resynchronization therapy.
Ada Torres
Ada Torres
22 May 2025
Echo IQ’s application for a key US procedural code was rejected but the company plans a swift resubmission, maintaining confidence in its US commercial rollout.
Ada Torres
Ada Torres
21 May 2025
Nufarm reports a mixed 1H25 with strong crop protection gains offset by a sharp decline in seed technologies earnings, prompting a strategic review of its seed business amid omega-3 market challenges.
Ada Torres
Ada Torres
21 May 2025